TY - JOUR
T1 - Regulation of myocardial glycogenolysis during post-ischemic reperfusion
AU - Kalil-Filho, Roberto
AU - Gerstenblith, Gary
AU - Hansford, Richard G.
AU - Chacko, V. P.
AU - Vandegaer, Koenraad
AU - Weiss, Robert G.
N1 - Funding Information:
We thank Dr Myron L. Weisfeldt for encouragement and support and MS Eileen Glickson for technical assistance. This work was supported in part by NIH grant HL-17655-16 and was done during the tenure of R.G.W. as a Clinician Scientist of the American Heart Association and as the Merck Clinician Scientist of the Johns Hopkins University School Medicine.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1991/12
Y1 - 1991/12
N2 - Myocardial glycogen and the factors which primarily regulate its metabolism were studied during post-ischemic reperfusion. Myocardial [13C]glycogen was continuously monitored by 13C-NMR spectroscopy in beating rat hearts perfused with oxygenated solutions containing [1-13C]glucose (5 mm) and insulin, during normal flow at 15 ml/min (n = 5), and during reperfusion after 30 min of 1 ml/min (n = 5), or 0 ml/min (n = 4) ischemia. Mean myocardial [13C]glycogen fell during reperfusion from 1.1 ± 0.6 at the end of zero-flow ischemia to 0.4 ± 0.4 μmol of [13C]glucosyl units/g wet wt (P<0.02) over the first 7 min of reperfusion; it also fell during reflow following 1 ml/min ischemia, from 2.3 ± 1.4 to 1.7 ± 1.0 μmol (P<0.03) over the same interval. In parallel experiments, glycogen phosphorylase % a(GPA%) content was higher at the end of 30 min of 0 ml/min (37.3 ± 7.3%, P<0.01), and trended higher after 1 ml/min flow (30.8 ± 12.1%, P=0.18) than under baseline conditions (20.1 ± 7.4%). However GPA% returned to baseline values within 1 min of reflow after both 0 and 1 ml/min ischemic periods (20.6 ± 3.0% and 19.0 ± 8.0%, respectively). Inorganic phosphate, as determined by simultaneous 31P-NMR, remained elevated during early reperfusion relative to baseline, and significantly correlated with the extent of decline in [13C]glycogen during reperfusion (r = 0.79, P<0.01). Thus, glycogen breakdown continues to occur during early post-ischemic reperfusion, but the mechanism is not related to elevated GPA%, and may be due to persistently increased inorganic phosphate at that time.
AB - Myocardial glycogen and the factors which primarily regulate its metabolism were studied during post-ischemic reperfusion. Myocardial [13C]glycogen was continuously monitored by 13C-NMR spectroscopy in beating rat hearts perfused with oxygenated solutions containing [1-13C]glucose (5 mm) and insulin, during normal flow at 15 ml/min (n = 5), and during reperfusion after 30 min of 1 ml/min (n = 5), or 0 ml/min (n = 4) ischemia. Mean myocardial [13C]glycogen fell during reperfusion from 1.1 ± 0.6 at the end of zero-flow ischemia to 0.4 ± 0.4 μmol of [13C]glucosyl units/g wet wt (P<0.02) over the first 7 min of reperfusion; it also fell during reflow following 1 ml/min ischemia, from 2.3 ± 1.4 to 1.7 ± 1.0 μmol (P<0.03) over the same interval. In parallel experiments, glycogen phosphorylase % a(GPA%) content was higher at the end of 30 min of 0 ml/min (37.3 ± 7.3%, P<0.01), and trended higher after 1 ml/min flow (30.8 ± 12.1%, P=0.18) than under baseline conditions (20.1 ± 7.4%). However GPA% returned to baseline values within 1 min of reflow after both 0 and 1 ml/min ischemic periods (20.6 ± 3.0% and 19.0 ± 8.0%, respectively). Inorganic phosphate, as determined by simultaneous 31P-NMR, remained elevated during early reperfusion relative to baseline, and significantly correlated with the extent of decline in [13C]glycogen during reperfusion (r = 0.79, P<0.01). Thus, glycogen breakdown continues to occur during early post-ischemic reperfusion, but the mechanism is not related to elevated GPA%, and may be due to persistently increased inorganic phosphate at that time.
KW - C-NMR
KW - Glycogen
KW - Ischemia
KW - Phosphorylase
UR - http://www.scopus.com/inward/record.url?scp=0026324267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026324267&partnerID=8YFLogxK
U2 - 10.1016/0022-2828(91)90192-O
DO - 10.1016/0022-2828(91)90192-O
M3 - Article
C2 - 1811061
AN - SCOPUS:0026324267
SN - 0022-2828
VL - 23
SP - 1467
EP - 1479
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 12
ER -